I am a 12‑week pregnant woman with a painful lump in my right breast; what are the possible causes and the recommended evaluation and management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Painful Breast Lump at 12 Weeks Pregnancy

You need breast ultrasound immediately to evaluate this lump, as while over 80% of breast masses in pregnancy are benign, pregnancy-associated breast cancer (PABC) is an aggressive malignancy that presents exactly like this and requires urgent diagnosis to prevent mortality. 1

Possible Causes

The differential diagnosis includes both benign and malignant etiologies:

Benign causes (>80% of cases):

  • Fibroadenomas - most common, may enlarge during pregnancy 1
  • Cysts - simple or complex
  • Lactating adenomas - variant of fibroadenoma specific to pregnancy 2
  • Breast abscess/mastitis - rare during pregnancy but possible 1
  • Infarction of pre-existing benign masses 1

Malignant cause:

  • Pregnancy-associated breast cancer (PABC) - occurs in 1 per 3,000 to 1 per 10,000 pregnancies but is increasing as women delay childbearing 1. These are biologically aggressive tumors, typically estrogen/progesterone receptor-negative and HER2-positive, presenting at more advanced stages with nodal involvement 1.

Critical Pitfall to Avoid

The physiological breast changes during pregnancy (enlargement, increased density, hormonal effects) make detection of abnormalities more difficult and contribute to delayed diagnosis of PABC. 1 Do not dismiss this lump as "normal pregnancy changes" - this delay results in larger, more advanced tumors with worse outcomes compared to non-pregnant women.

Recommended Evaluation Algorithm

Step 1: Immediate Breast Ultrasound

  • Ultrasound is the first-line imaging modality for evaluating any palpable breast mass during pregnancy 1, 3
  • It differentiates benign lesions (cysts, galactoceles) from solid masses requiring biopsy
  • Also evaluates axillary and supraclavicular lymph nodes 3

Step 2: Add Mammography if Indicated

  • Mammography is safe during pregnancy - scatter radiation to the fetus is negligible 1
  • Perform single mediolateral oblique view if ultrasound suggests malignancy 3
  • Helps detect microcalcifications or tissue distortions not visible on ultrasound 1
  • Can use digital breast tomosynthesis for better detection in dense pregnancy breast tissue 1

Step 3: Biopsy Based on Imaging Results

If ultrasound shows BI-RADS 2 (benign):

  • No further assessment needed if no suspicious clinical signs 4

If ultrasound shows BI-RADS 3 (probably benign):

  • Requires monitoring with ultrasound follow-up 1
  • Consider mammography depending on clinical context 4

If ultrasound shows ≥BI-RADS 4a (suspicious):

  • Perform image-guided core needle biopsy - this is safe during pregnancy 1
  • Core biopsy preferred over fine needle aspiration (FNA has higher false-positive rate due to difficulty distinguishing pregnancy-related cellular changes from neoplasia) 1
  • Discuss risks: increased bleeding (due to breast vascularization), milk fistula (low risk at 12 weeks, increases closer to delivery) 1

Step 4: If Infection Suspected

Look for signs of mastitis/abscess:

  • Redness, tenderness, fever 1
  • Start antibiotics immediately if infection signs present 1
  • If infection does not respond to antibiotics, suspect inflammatory breast cancer and proceed with full workup 1

Important Nuances

Benign lesions can appear atypical during pregnancy due to enlargement or infarction and may warrant biopsy for confirmation 1. Conversely, some cancers can exhibit seemingly reassuring characteristics 4. Therefore, strict BI-RADS scoring must be applied but with awareness of these pregnancy-specific changes.

Avoid gadolinium-enhanced MRI - IV gadolinium crosses the placenta, dissociates into toxic free gadolinium ions in amniotic fluid, and is contraindicated during pregnancy 1. Non-contrast MRI with diffusion-weighted imaging can be considered in selected cases to delineate tumor extent if malignancy is confirmed 3.

Management Depends on Final Diagnosis

  • If benign and concordant on triple assessment: Conservative management with follow-up 2
  • If PABC confirmed: Requires multidisciplinary team management with surgery (safe at any trimester), chemotherapy (safe after 12 weeks gestation), but hormone therapy is contraindicated 3, 5

The key message: Do not delay evaluation. PABC has worse outcomes due to diagnostic delays, and early detection through prompt imaging and biopsy when indicated is essential for maternal survival. 1, 6

References

Guideline

acr appropriateness criteria® breast imaging during pregnancy.

Journal of the American College of Radiology, 2025

Research

Benign Disorders of the Breast in Pregnancy and Lactation.

Advances in experimental medicine and biology, 2020

Research

Breast lumps in pregnant women.

Diagnostic and interventional imaging, 2015

Research

Management and treatment of breast cancer in pregnant women.

Archives of medical science : AMS, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.